Periodontal Disease

Disease

Also known as: gum disease

Related News

Medivir Reports 2025 Annual Results with Key Clinical and Financial Milestones

Medivir's 2025 Annual Report highlights FDA Orphan Drug Designation for MIV-711 in Osteogenesis Imperfecta and promising fostrox liver cancer data showing 13.7-month median survival. The company raised SEK 196 million to fund Phase 2 studies for both programs and reported year-end cash of SEK 119.2 million.

Related Clinical Trials

NCT ID Title Status Phase
NCT07770906

Effect of GLP-1 Receptor Agonists on Periodontal Health and Response to Nonsurgical Periodontal Therapy

NOT_YET_RECRUITING NA
NCT07759466

Hippo Signaling Pathway Proteins in Gingival Crevicular Fluid of Individuals With Periodontal Disease

COMPLETED
NCT07745803

Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma

NOT_YET_RECRUITING
NCT07737678

Evaluation of NIPSA Using Alloplastic Bone Graft and Cross-Linked Hyaluronic Acid in theTreatment of Intrabony Defects

NOT_YET_RECRUITING PHASE1/PHASE2
NCT07731113

Evaluation of Hyaluronic Acid and Chlorhexidine Gel as an Adjunct to Minimally Invasive Non-surgical Therapy in the Treatment of Stage III and IV Periodontitis

ACTIVE_NOT_RECRUITING NA
NCT07725913

Thermosensitive Hyaluronic Gel With Octenidine as an Adjunctive to Subgingival Instrumentation. Spontaneous, Postmarketing Trial With a Medical Device (MD), Split-mouth, Nationwide Multicenter Study Single-blind Randomized Controlled Trial

RECRUITING NA
NCT07725276

Comparing the Efficacy of Toothbrushing With and Without Interproximal Cleaning Aids: A Split-Mouth Trial

COMPLETED NA
NCT07721428

Salivary Angiotensin-Converting Enzyme and Periodontal Disease in Cardiovascular Disease

COMPLETED
NCT07718074

Probiotic Response in Periodontal Disease

NOT_YET_RECRUITING NA
NCT07711431

Association Between Periodontal Disease and Chronic Neck Pain

RECRUITING